Qing Pu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mechanism of Jiedu Prescription in Hepatocellular Carcinoma: Integrating Network Pharmacology and Experimental Validation.
Journal: Integrative cancer therapies
Published: October 23, 2025
Value of CD8+ T cell-related genes and IL-6/STAT3 signaling pathway in the prognosis of HCC and experimental investigation.
Journal: International journal of biological macromolecules
Published: June 04, 2025
Tetramethylpyrazine: A fermented alcohol product that mitigates alcoholic liver disease in mice.
Journal: Free radical biology & medicine
Published: March 17, 2025
Xihuang pill suppressed primary liver cancer growth by downregulation of AFP and YAP signaling.
Journal: Journal of ethnopharmacology
Published: January 02, 2025
Based on Soluble Immune Checkpoints Constructing a Random Survival Forest Model to Predict the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Journal: OncoTargets and therapy
Published: December 17, 2024
Prognostic value of CD8+T cells related genes and exhaustion regulation of Notch signaling pathway in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: January 24, 2024
Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study.
Journal: Frontiers in pharmacology
Published: December 13, 2023
A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age.
Journal: OncoTargets and therapy
Published: June 16, 2023
Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8+T Cell Counts.
Journal: OncoTargets and therapy
Published: May 11, 2022
Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy.
Journal: Frontiers in cell and developmental biology
Published: May 10, 2022
Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis.
Journal: Journal of Cancer
Published: May 07, 2022
The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 28, 2022
Last Updated: 09/26/2026